Revolution Medicines, Inc. — Director's Dealing 2020

Feb 13, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Revolution Medicines, Inc. (RVMD)
CIK: 0001628171
Period of Report: 2020-02-12

Reporting Person: Horn Margaret A (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	123302	Indirect
Common Stock	10454	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.54	2028-02-11	Common Stock (13441)		Direct
Stock Option (Right to Buy)	$4.73	2029-08-08	Common Stock (224800)		Direct
Stock Option (Right to Buy)	$4.09	2029-03-12	Common Stock (102751)		Direct
Stock Option (Right to Buy)	$4.09	2029-03-12	Common Stock (123302)		Direct

Footnotes

F1: Reflects a 1-for-4.8661 reverse stock split of the Issuer's outstanding securities effected prior to the effectiveness of the Issuer's S-1 Registration Statement.

F2: Held by Margaret A. Horn Revocable Living Trust.

F3: This option is early exercisable. One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2018 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

F4: This option is early exercisable. One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

F5: This option is early exercisable. One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

F6: This option is early exercisable. One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 13, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.